Zobrazeno 1 - 10
of 78
pro vyhledávání: '"V G Radchenko"'
Publikováno v:
Терапевтический архив, Vol 88, Iss 9, Pp 78-83 (2016)
Aim. To determine the incidence of biliary sludge (BS) and to evaluate the clinical efficacy of Chophytol in patients with nonalcoholic steatohepatitis (NASH) and BS in the presence of metabolic syndrome (MS). Subjects and methods. Clinical laborator
Externí odkaz:
https://doaj.org/article/1bd36eabdecb4ca0b6c3f67320fd0097
Publikováno v:
Терапевтический архив, Vol 86, Iss 4, Pp 52-57 (2014)
AIM: To evaluate the efficacy of the symbiotic Linex used in the combination therapy of liver cirrhosis (LC)/MATERIAL AND METHODS: Seventy-four patients with LC, including 44 who received additionally the symbiotic Linex and 30 who had conventional t
Externí odkaz:
https://doaj.org/article/22a046b2d59a4893bf3e99eee24385b2
Autor:
Viktoriya Valer'evna Stel'makh, Valeriy Grigor'evich Radchenko, Viktor Konstantinovich Kozlov, V V Stelmakh, V G Radchenko, V K Kozlov
Publikováno v:
Терапевтический архив, Vol 83, Iss 2, Pp 67-71 (2011)
Chronic viral hepatitides (CVH) run with long-term activation of the system of mononuclear phagocytes associated with hyperproduction of active oxygen forms. This can be considered as risk factors of antioxidant insufficiency which determines the cou
Externí odkaz:
https://doaj.org/article/48c9b916afd745e4a9ce0024e11823b1
Autor:
Tamara Vasil'evna Sologub, Mikhail Grigor'evich Romantsov, Andrey Anatol'evich Shul'dyakov, Yuliya Nikolaevna Lin'kova, Valeriy Grigor'evich Radchenko, Aleksey Leonidovich Kovalenko, T V Sologub, M G Romantsov, A A Shuldyakov, Yu N Linkova, V G Radchenko, A L Kovalenko
Publikováno v:
Терапевтический архив, Vol 82, Iss 10, Pp 78-78 (2010)
The results of a study of the efficiency of treatment in patients with chronic hepatitis C conducted in a complex of multicenter clinical trials of the impact of various antiviral therapy regimens including the interferon genesis inductor cycloferon
Externí odkaz:
https://doaj.org/article/0dd799d973704ce4a582a86bce3f18d2
Autor:
V. B. Grinevich, L. B. Lazebnik, Yu. A. Kravchuk, V. G. Radchenko, E. I. Tkachenko, A. M. Pershko, P. V. Seliverstov, C. P. Salikova, K. V. Zhdanov, K. V. Kozlov, V. V. Makienko, I. V. Potapova, E. S. Ivanyuk, D. V. Egorov, E. I. Sas, M. D. Korzheva, N. M. Kozlova, A. K. Ratnikova, V. A. Ratnikov, S. I. Sitkin, L. Z. Bolieva, C. V. Turkina, D. I. Abdulganieva, T. V. Ermolova, S. A. Kozhevnikova, L. V. Tarasova, R. G. Myazin, N. M. Khomeriki, T. L. Pilat, L. P. Kuzmina, R. A. Khanferyan, V. P. Novikova, A. V. Polunina, A. I. Khavkin
Publikováno v:
Experimental and Clinical Gastroenterology. :4-68
Summary Post- COVID syndrome refers to the long-term consequences of a new coronavirus infection COVID-19, which includes a set of symptoms that develop or persist after COVID-19. Symptoms of gastrointestinal disorders in post- COVID syndrome, due to
Autor:
L. B. Lazebnik, E. V. Golovanova, S. A. Alekseenko, A. O. Bueverov, E. Y. Plotnikova, A. I. Dolgushina, L. Y. Ilchenko, T. V. Ermolova, L. V. Tarasova, E. D. Lee, Y. V. Tsyganova, V. A. Akhmedov, E. A. Ageeva, V. M. Losev, I. N. Kupriyanova, S. N. Serikova, N. V. Korochanskaya, L. G. Vologzhanina, Y. S. Zimmerman, E. I. Sas, S. V. Zhuravel, S. V. Okovitiy, M. F. Osipenko, V. G. Radchenko, G. S. Soldatova, S. I. Sitkin, P. V. Seliverstov, G. V. Shavkuta, E. N. Butova, S. A. Kozhevnikova
Publikováno v:
Experimental and Clinical Gastroenterology. :154-172
Hyperammonemia is an acute or chronic intoxication with ammonia and ammonium associated with elevated ammonia levels in serum due to either its increased production and/or decreased detoxification. Hyperammonemia can result from a variety of causes a
Autor:
P. I. Seliverstov, V. G. Radchenko
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 24, Iss 4, Pp 39-44 (2014)
Aim of investigation. To estimate efficacy of combined hepatotropic drug «Hepaguard Active» for prevention of progression of non-alcoholic fatty liver disease (NAFLD) at steatosis stage.Material and methods. Overall 25 patients with verified NAFLD
Externí odkaz:
https://doaj.org/article/5ba22fc738fb424881a1d840dd17e5cb
Autor:
O P Dudanova, V. G. Radchenko, Anastasiya Andreevna Shipovskaya, V. N. Marchenko, I. V. Kurbatova, P. V. Selivyorstov
Publikováno v:
Медицинский совет, Vol 0, Iss 5, Pp 68-74 (2021)
Introduction. NAFLD is an urgent health problem, its prevalence reaches 45%. NAFLD increases the risk of cardiovascular diseases by 3 times, the risk of death from them by 2 times and increases the risk of developing diabetes by 5 times. NAS occupies
Autor:
S. V. Okovity, O. V. Ivanova, A. A. Boykova, N. M. Kalinina, N. I. Davydova, V. G. Radchenko, S. N. Shulenin
Publikováno v:
Медицинская иммунология, Vol 7, Iss 1, Pp 93-99 (2014)
Abstract. Introduction of bemithyl into combined therapy of patients suffering chronic hepatitis allows toachieve a noticeable hepatoprotective effect. Apparently it is realized due to direct hepatotropic influence as well as through immunomodulatory
Externí odkaz:
https://doaj.org/article/f78bb58f221a46139c19c4e4212f887c
Autor:
E. A. Nikitin, K. V. Kleymenov, D. D. Batienco, D. A. Akulenko, P. V. Seliverstov, V. P. Dobritsa, V. G. Radchenko
Publikováno v:
Медицинский совет, Vol 0, Iss 21, Pp 240-246 (2020)
Sepsis is a systemic pathological reaction that arise because of a severe infection. Now, sepsis is considered as one of the most serious diseases and materially expensive nosology’s. For instance, out of 100% of cases of sepsis, only 40% survive.